Aveanna Healthcare Holdings Inc.
NASDAQ:AVAHMedical - Care Facilities
+$0.10 today
- Market cap
- $2.37B
- Beta
- 1.93
- P/E (TTM)
- 6.3
- EPS (TTM)
- $1.22
Volume 2.12M
Average 1.52M
AVAH Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Aveanna Healthcare Holdings Inc.NASDAQ: AVAH
Cost of Revenue · Q3 FY2026 · quarter ended Oct 2026
Cost of revenue grows, but more slowly than its trailing trend
Q3 FY2026 cost of revenue of $468.78M rose 11.2% year over year, behind the +19.3% change in trailing-twelve-month cost of revenue. Sequentially, it rose 3.7% from the prior quarter. Over 3 fiscal years it compounded at +9.7% a year.
Context
- Cost of revenue amounted to 66.9% of revenue in FY2025, down 1.7 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +11.2% toward the trailing-twelve-month pace of +19.3%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 1.63B USD
- Year-over-year change
- +17.2%
- 4-year CAGR
- +9.4%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 1.63B | +17.2% |
| FY2024 | 2024-12-28 | 1.39B | +6.9% |
| FY2023 | 2023-12-31 | 1.3B | +5.3% |
| FY2022 | 2022-12-31 | 1.23B | +8.6% |
| FY2021 | 2021-12-31 | 1.14B | — |
Cost of Revenue vs competitors
How AVAH compares with its peers on the latest reported figures
- AVAH's LTM Oct 2026 cost of revenue of $1.82B is the 3rd highest of the 7 companies compared; the peer median is $1.4B.
- Its year-over-year change of +19.3% is the 3rd highest of 7, against a peer median of +12.3%.
- Cost of revenue amounts to 67.9% of revenue for AVAH, versus a peer median of 68.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $4.69B | +4.1% | +14.6% | 81.5% | |
| LTM Jun 2026 | $3.48B | +6.6% | +9.1% | 56.1% | |
| LTM Oct 2026 | $1.82B | +19.3% | +9.7% | 67.9% | |
| LTM Jun 2026 | $1.81B | +8.3% | +9.0% | 69.6% | |
| LTM Jun 2026 | $998.65M | +16.3% | +13.8% | 67.6% | |
| LTM Mar 2026 | $871.95M | +35.1% | +25.8% | 85.2% | |
| LTM Mar 2026 | $122.3M | +27.2% | +28.5% | 42.7% | |
| Peer median (excluding AVAH) | $1.4B | +12.3% | +14.2% | 68.6% | |
Competitors are the stored peer set for AVAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.68B | 1.79B | 1.9B | 2.02B | 2.43B |
| Cost of Revenue | 1.14B | 1.23B | 1.3B | 1.39B | 1.63B |
| Gross Profit | 542.4M | 553.23M | 595.43M | 635.54M | 805.15M |
| Gross Margin | 32.3% | 30.9% | 31.4% | 31.4% | 33.1% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 419.64M | 483.95M | 464.74M | 470.47M | 526.74M |
| Operating Expenses | 578.52M | 1.2B | 587.36M | 495.76M | 539.77M |
| Depreciation & Amortization | 35.39M | 38.82M | 30.1M | 31.16M | 28.22M |
| EBITDA | (17.96M) | (525.06M) | 39.17M | 187.38M | 279.02M |
| EBITDA Margin | -1.1% | -29.4% | 2.1% | 9.3% | 11.5% |
| Operating Income | (36.11M) | (642.28M) | 8.07M | 139.79M | 265.38M |
| Operating Margin | -2.2% | -35.9% | 0.4% | 6.9% | 10.9% |
| Interest Income | 253K | 679K | 327K | 498K | 2.83M |
| Interest Expense | 68.93M | 107.72M | 153.25M | 156.6M | 140.09M |
| Other Income / Expenses | (77.47M) | (21.54M) | (147.07M) | (134.72M) | (158.43M) |
| Income Before Tax | (113.58M) | (663.81M) | (139M) | 5.07M | 106.95M |
| Pre-Tax Margin | -6.8% | -37.1% | -7.3% | 0.3% | 4.4% |
| Income Tax Expense | 3.47M | (1.78M) | (4.47M) | 16M | (118.09M) |
| Net Income | (117.04M) | (662.03M) | (134.52M) | (10.93M) | 225.03M |
| Net Margin | -7.0% | -37.0% | -7.1% | -0.5% | 9.2% |
| EPS (Basic) | (0.63) | (3.57) | (0.71) | (0.06) | 1.10 |
| EPS (Diluted) | (0.63) | (3.57) | (0.71) | (0.06) | 1.05 |
| Weighted Avg Shares | 184.73M | 185.55M | 189.96M | 192.89M | 203.53M |
| Weighted Avg Shares (Diluted) | 184.73M | 185.55M | 189.96M | 192.89M | 214.98M |
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
Intrinsic Alpha fair value
Locked
Current Price
$10.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.